Related Experiment Video
Updated: Feb 10, 2026

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.5K
[PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.]
Eksperimental'Naia I Klinicheskaia Farmakologiia
|May 24, 2018
Summary
Pharmacogenetic markers influence treatment effectiveness in pediatric asthma. Specific gene variants, like the Gly16 allele, are linked to poor response to common asthma medications, including short-acting beta-agonists and inhaled corticosteroids.
Area of Science:
- Pediatric Pulmonology
- Pharmacogenetics
- Asthma Research
Background:
- Asthma treatment effectiveness varies significantly in children.
- Genetic factors are suspected to play a role in this variability.
- Understanding these factors can personalize treatment strategies.
Purpose of the Study:
- To identify pharmacogenetic markers associated with treatment response in pediatric asthma.
- To investigate the impact of specific gene variants on the efficacy of common asthma medications.
Main Methods:
- Analysis of pharmacogenetic data in children with atopic asthma.
- Correlation of genetic polymorphisms with treatment outcomes for glucocorticosteroids, leukotriene receptor antagonists, and beta2-adrenergic receptor agonists.
Main Results:
- Variability in treatment response was observed across different drug classes.
- The Gly/Gly genotype of the beta2-adrenergic receptor gene (ADRB1) was associated with a diminished response to short-acting beta2-agonists.
- The Gly16 allele and CYP2D6 -1934GG genotype were linked to severe asthma phenotypes and reduced treatment efficacy.
Conclusions:
- Pharmacogenetic markers significantly influence treatment outcomes in pediatric asthma.
- Genetic profiling may aid in predicting treatment response and optimizing therapy for children with asthma.
- Targeting specific genetic variants could lead to more effective and personalized asthma management strategies.
Related Concept Videos
The Bronchial Tree
6.9K
The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
6.9K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
Asthma-II: Pathophysiology and Classification
4.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.4K

